Clindamycin vs Ipilimumab

Clindamycin vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Clindamycin and Ipilimumab.

Mechanism of Action

Clindamycin: Binds 50S ribosomal subunit inhibiting protein synthesis.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Clindamycin — 2-3 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Clindamycin — C18H33ClN2O5S.

Molecular Weight: Clindamycin — 424.9830 g/mol.

Type: Clindamycin — Small molecule; Ipilimumab — Antibody.